WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004006851) MYCOPLASMA GALLISEPTICUM FORMULATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/006851    International Application No.:    PCT/US2003/022011
Publication Date: 22.01.2004 International Filing Date: 10.07.2003
Chapter 2 Demand Filed:    23.01.2004    
IPC:
A61K 39/00 (2006.01), A61K 39/02 (2006.01), A61K 39/38 (2006.01), A61K 39/385 (2006.01)
Applicants: THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. [US/US]; 630 Boyd Graduate Studies Research Center, Athens, GA 30602 (US) (For All Designated States Except US).
KLEVEN, Stanley, H. [US/US]; (US) (For US Only).
FERGUSON, Naola [TT/US]; (US) (For US Only)
Inventors: KLEVEN, Stanley, H.; (US).
FERGUSON, Naola; (US)
Agent: SHELTON, Dennis K.; Christensen O'Connor Johnson, Kindness PLLC, 1420 Fifth Avenue, Suite 2800, Seattle, WA 98101 (US)
Priority Data:
10/194,180 13.07.2002 US
Title (EN) MYCOPLASMA GALLISEPTICUM FORMULATION
(FR) FORMULATION DE MYCOPLASMA GALLISEPTICUM
Abstract: front page image
(EN)The present invention provides a protective formulation that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes. The formulation comprises a protective amount of live MG strain K5054 or derivatives thereof in a pharmaceutically acceptable carrier. A vaccine that prevents virulent Mycoplasma gallisepticum infection in birds of the order Galliformes is also presented. Methods for administering the formulation and vaccine are also presented.
(FR)L'invention concerne une formulation protectrice qui permet de prévenir une infection par Mycoplasma gallisepticum virulent chez des oiseaux de l'ordre des galliformes. Cette formulation comprend une quantité protectrice de la souche de MG vivant K5054, ou de dérivés de celle-ci, dans un excipient pharmaceutiquement acceptable. L'invention concerne aussi un vaccin permettant de prévenir une infection par Mycoplasma gallisepticum virulent chez des oiseaux de l'ordre des galliformes, ainsi que des procédés d'administration de la formulation et du vaccin.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)